Someone in my house has COVID. How likely am I to catch it?

Throughout the pandemic, one of the biggest COVID risks has been sharing a house with someone who is infectious.

COVID-19 associated with increase in new diagnoses of type 1 diabetes in youth, by as much as 72%

Children who were infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study that analyzed electronic health records of more than 1 million patients ages 18 and younger.

Friend or foe? How mice decide to make love or war

Dog owners whose pets meet during a walk are familiar with the immediate sniffing investigation that typically ensues. Initially, the owners cannot tell whether their dogs will wind up fighting, playing, or trying to mount each other. Something is clearly happening in the dog's brain to make it decide how to behave toward the other dog—but what is going on?

Fourth SARS-CoV-2 vaccination also protects cancer patients

A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports fourth vaccination for this vulnerable group. However, passive immunization by administering an antibody combination to cancer patients does not seem to provide adequate protection. The study has now been published in the journal JAMA Oncology.

Landmark study of biomarker data may enable better treatment for early onset dementia

Frontotemporal dementia (FTD), a common form of early-onset dementia, is marked by impairments in behavior, language, and sometimes motor function. Unlike Alzheimer's Disease (AD), researchers and clinicians have been unable to accurately predict the onset of symptoms for individuals having a familial form of the condition.

Pin-prick blood test identifies immunity to COVID-19

A finger-prick blood test can identify people most at risk of being reinfected with COVID-19. The simple test, developed by a small biotech firm based in Cardiff (ImmunoServ Ltd) in close collaboration with Cardiff University researchers, measures the presence of immune T cells that can recognize SARS-CoV-2.